| 摘要 |
<p>The present invention relates to a pharmaceutical composition comprising a lipase inhibitor, preferably orlistat, having a melting point ≥37°C, a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients.</p> |
